R. Plante

发表

Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.

C. Lau, S. M. Kazmi, R. Plante, 1996, Cancer research.

Suppression of NFκB activation and NFκB‐dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5‐lipoxygenase

Lubing Zhou, C. Lau, S. M. Kazmi, 1995 .

Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase.

L. Zhou, C. Lau, S. M. Kazmi, 1995, Journal of cellular biochemistry.

O-154 Impact of maintaining Hb with epoetin alfa on time toprogression (TTP), overall survival (OS), quality of life (QOL) and transfusion reduction in limited disease SCLC patients

A. Bezjak, G. Perry, Colum J Smith, 2005 .

Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.

M. Kovacs, I. Quirt, C. Lau, 2006, The oncologist.

Novel intracellular signaling function of prostaglandin H synthase-1 in NF-kappa B activation.

D. Munroe, L. Zhou, S. M. Kazmi, 1995, Journal of inflammation.

Tepoxalin enhances the activity of an antioxidant, pyrrolidine dithiocarbamate, in attenuating tumor necrosis factor alpha-induced apoptosis in WEHI 164 cells.

B. Pope, C. Lau, G. R. Taylor, 1999, The Journal of pharmacology and experimental therapeutics.

Tissue-specific activity of the pro-opiomelanocortin gene promoter

J. Drouin, L. Jeannotte, M. Trifiro, 1987, Molecular and cellular biology.

Cytokine-modulating activity of tepoxalin, a new potential antirheumatic.

D. Ritchie, C. Lau, R. Plante, 1995, International journal of immunopharmacology.

Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription

J. Drouin, P. Eriksson, O. Wrange, 1989, Molecular and cellular biology.

Pro‐opiomelanocortin gene: A model for negative regulation of transcription by glucocorticoids

J. Drouin, J. Charron, M. Nemer, 1987, Journal of cellular biochemistry.

Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC.

J. Chin, A. Zardan, A. Feifer, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

CUAJ – Original Research Gotto et al PROs in mCRPCP: Final results of COSMiC

A. Zardan, A. Feifer, V. Fradet, 2020 .

Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy.

A. Levin, R. Foley, P. Parfrey, 2000, Kidney international.

Differential regulation of human progesterone receptor A and B form-mediated trans-activation by phosphorylation.

C. Lau, S. M. Kazmi, A. Ishaque, 1993, Endocrinology.

The NF-kappa B inhibitor, tepoxalin, suppresses surface expression of the cell adhesion molecules CD62E, CD11b/CD18 and CD106.

C. Lau, G. R. Taylor, R. Plante, 1996, Immunology letters.

Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.

I. Quirt, C. Lau, B. Melosky, 2005, The oncologist.

Bortezomib [VELCADE™], Pegylated Liposomal Doxorubicin [DOXIL/CAELYX®] and Dexamethasone in the Treatment of Previously Untreated Multiple Myeloma Patients: Impact on Quality-of-Life.

A. Belch, D. Reece, D. White, 2007 .

The NF-κB inhibitor, tepoxalin, suppresses surface expression of the cell adhesion molecules CD62E, CD11bCD18 and CD106

C. Lau, G. R. Taylor, R. Plante, 1996 .